Najarian John S
Department of Surgery, Fairview-University Medical Center, Minneapolis, Minnesota, USA.
Transplant Proc. 2005 Nov;37(9):3592-4. doi: 10.1016/j.transproceed.2005.10.079.
Short- and long-term living kidney donor morbidity and mortality are discussed herein. The analysis includes over 3000 living donor kidney transplants from 1963 through 2002 at a single institution. The category of living donors includes living related donors, such as fathers, mothers, siblings, offspring, and other genetically related donors, as well as living unrelated donors, such as spouses, friends, or altruistic strangers. Graft and patient survival rates with living related and unrelated living donors are compared to rates with cadaveric donors. Donor risks are discussed, including short-term surgical risks as well as long-term risks of impaired renal function, possible hypertension, and psychological risks. Finally, early and late donor mortality statistics are presented. In addition, the benefits to potential donors are reviewed. Donors are carefully screened before donation. During this screening process, a significant number of donors have been found to have abnormal renal function--some had undisclosed hypertension and others had unknown cardiovascular disease. In addition, six malignancies were found, eventually resulting in curative resection. A secondary benefit to donors was reported in a study from Norway and Sweden, which showed that donors had improved long-term survival versus the general population. Our own long-term studies involving follow-up of 20 to 30 years after kidney donation have shown no significant difference in donor renal function, blood pressure, and incidence of proteinuria, as compared with their nondonor siblings. We also found donors to be perfectly normal in all other categories; several had even undergone normal pregnancies after donation. Most donors reported a high quality of life, with a boost in self-esteem and an increased sense of well-being: 96% felt it was a positive experience. In conclusion, living kidney donation has a very low mortality rate. Long-term follow-up shows minimal impact after donation. Donor quality of life is reported as excellent.
本文讨论了活体肾供者的短期和长期发病率及死亡率。分析涵盖了1963年至2002年在单一机构进行的3000多例活体供肾移植。活体供者类别包括活体亲属供者,如父亲、母亲、兄弟姐妹、子女及其他有血缘关系的供者,以及活体非亲属供者,如配偶、朋友或利他陌生人。将活体亲属和非亲属供者的移植物及患者生存率与尸体供者的生存率进行了比较。讨论了供者风险,包括短期手术风险以及肾功能受损、可能出现的高血压和心理风险等长期风险。最后给出了供者早期和晚期死亡率统计数据。此外,还回顾了对潜在供者的益处。供者在捐献前会经过仔细筛查。在此筛查过程中,发现大量供者肾功能异常——一些人有未披露的高血压,另一些人有未知的心血管疾病。此外,还发现了6例恶性肿瘤,最终均进行了根治性切除。挪威和瑞典的一项研究报告了供者的第二个益处,即与普通人群相比,供者的长期生存率有所提高。我们自己的长期研究对肾移植后20至30年进行随访,结果显示,与未捐献的兄弟姐妹相比,供者的肾功能、血压和蛋白尿发生率无显著差异。我们还发现供者在所有其他方面完全正常;有几人甚至在捐献后正常怀孕。大多数供者报告生活质量很高,自尊增强,幸福感增加:96%的人认为这是一次积极的经历。总之,活体肾捐献的死亡率非常低。长期随访表明捐献后影响极小。据报告,供者的生活质量极佳。